Mar 15, 2023 / 02:15PM GMT
Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst
All right. Good morning, everybody. My name is Luke Sergott. I cover Life Sciences Tools and Diagnostics here at Barclays. With me today, it's my pleasure to have James Foster, CEO of Charles River, also known Jim Foster, whatever preference is.
Questions and Answers:
Luke England Sergott - Barclays Bank PLC, Research Division - Research AnalystSo a lot to dig in here. So a lot of interesting topics to cover, but can we start off first talking about the [SAP] exposure and then the impacts that you're seeing from the customer base? Have you guys broken that out by the revs, I think you had something in your deck on it, but just anything that you're seeing there?
James C. Foster - Charles River Laboratories International, Inc. - Chairman, CEO & President
Not seeing anything adverse. I don't just kind of (inaudible) from clients. We see saying all is good. So we don't expect that's going to have an impact on us.
Trustpilot
